title: Therapy of H7N9 pneumonia: current perspectives.
authors.affiliation: Department of Infectious Diseases and Clinical Microbiology, Capital Medical University, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, 100020, Beijing, China.
authors.forename: Bin
authors.initials: B
authors.lastname: Cao
authors.forename: Frederick G
authors.initials: FG
authors.lastname: Hayden
mesh_terms: D000146:Acids, Carbocyclic; D000998:Antiviral Agents / Q000627:therapeutic use; D003517:Cyclopentanes / Q000627:therapeutic use; D024882:Drug Resistance, Viral; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D064766:Influenza A Virus, H7N9 Subtype / Q000187:drug effects*; D007251:Influenza, Human / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D053139:Oseltamivir / Q000627:therapeutic use; D012123:Pulmonary Ventilation; D053243:Zanamivir / Q000627:therapeutic use
chemical_list: D000146:Acids, Carbocyclic; D000998:Antiviral Agents; D003517:Cyclopentanes; D006146:Guanidines; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir; C414210:peramivir